We are live on
!
Find out more
OCM
Oakview Capital Management Portfolio holdings
AUM
$21.6M
1-Year Est. Return
20.25%
This Fund
S&P 500
This Quarter
Est. Return
+6.55%
1 Year Est. Return
+20.25%
3 Year Est. Return
+21.24%
5 Year Est. Return
+60.68%
10 Year Est. Return
–
AUM
$177M
AUM Growth
–
Cap. Flow
+$173M
Cap. Flow
% of AUM
97.42%
Top 10 Holdings %
Top 10 Hldgs %
82.88%
Holding
47
New
46
Increased
–
Reduced
–
Closed
–
Top Buys
| 1 |
Orthofix Medical
OFIX
|
+$18.8M |
| 2 |
Pfizer
PFE
|
+$17.8M |
| 3 |
General Motors
GM
|
+$15.7M |
| 4 |
FMC
FMC
|
+$15.5M |
| 5 |
NetApp
NTAP
|
+$14.1M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 32.28% |
| 2 | Materials | 14.8% |
| 3 | Consumer Discretionary | 14.6% |
| 4 | Financials | 13.24% |
| 5 | Energy | 8.64% |
Similar funds
KLM
SRCM
CMG
TM
A
WA
LC
TOTSC
Oakview Capital Management's Q4 2016 Portfolio in Review
Q4 2016 is the first quarter with a 13F filing on record for Oakview Capital Management, which disclosed 47 positions worth $177M. Its ten largest holdings account for 83% of the portfolio.
Its largest position is Orthofix Medical: 496,208 shares worth $18M.
By sector, the portfolio is most concentrated in Healthcare at 32% of assets, followed by Materials and Consumer Discretionary.
- Oakview Capital Management's largest Q4 2016 buy was Orthofix Medical: 496,208 shares worth $18M.
- Oakview Capital Management's ten largest holdings make up 83% of its $177M portfolio in Q4 2016.
- Oakview Capital Management disclosed 47 positions in Q4 2016, its first 13F filing on record.
Based on Oakview Capital Management's 13F filing for Q4 2016, filed 15 Feb 2017.